INOZYME PHARMA INC. -
5.2300
08-أكتوبر-24 12:33:59
15 متأخرة بدقائق
الأسهم
+0.0100
+0.19%
نطاق اليوم
5.2200 - 5.4552
ISIN
N/A
المصدر
NASDAQ
-
09 يونيو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Q1 2021 Financial Results and Provides Business Highlights
12 مايو 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
07 مايو 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the BofA Securities 2021 Virtual Healthcare Conference
06 مايو 2021 07:30:01 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Publishes Data Supporting INZ-701 as a Potential Treatment for ENPP1 Deficiency
29 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
08 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Expands its Scientific Advisory Board
01 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights
25 مارس 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
11 مارس 2021 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer
04 فبراير 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
04 يناير 2021 06:00:00 بحسب Nasdaq GlobeNewswire